Muskil, Ailyn .

HRN: 26-57-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFTRIAXONE 1G (VIAL)
01/23/2025
01/30/2025
IVT
1750 Mg
Q 24h
T/c Mild TBI; Multiple Soft Tissue Injuries Sec To MVA; S/P Wound Suturing (01/23/25)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: